Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microarray-Based Detection of Antibodies against SARS-CoV-2 Proteins, Common Respiratory Viruses and Type I Interferons
Elena Savvateeva, М. А. Филиппова, Vladimir T. Valuev-Elliston, et al.
Viruses (2021) Vol. 13, Iss. 12, pp. 2553-2553
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
Jérémy Manry, Paul Bastard, Adrian Gervais, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 21
Open Access | Times Cited: 160
From rare disorders of immunity to common determinants of infection: Following the mechanistic thread
Jean‐Laurent Casanova, Laurent Abel
Cell (2022) Vol. 185, Iss. 17, pp. 3086-3103
Open Access | Times Cited: 106
Autoantibodies against type I IFNs in patients with critical influenza pneumonia
Qian Zhang, Andrés Pizzorno, Lisa Miorin, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 11
Open Access | Times Cited: 81
Unlocking life-threatening COVID-19 through two types of inborn errors of type I IFNs
Jean‐Laurent Casanova, Mark S. Anderson
Journal of Clinical Investigation (2023) Vol. 133, Iss. 3
Open Access | Times Cited: 46
Human autoantibodies neutralizing type I IFNs: From 1981 to 2023
Paul Bastard, Adrian Gervais, Tom Le Voyer, et al.
Immunological Reviews (2024) Vol. 322, Iss. 1, pp. 98-112
Open Access | Times Cited: 29
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children
Paul Bastard, Adrian Gervais, Maki Taniguchi, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 2
Open Access | Times Cited: 24
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs
Paul Bastard, Sara E. Vazquez, Jamin Liu, et al.
Science Immunology (2022) Vol. 8, Iss. 90
Open Access | Times Cited: 62
Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease
Idoia Busnadiego, Irène A. Abela, Pascal M. Frey, et al.
PLoS Biology (2022) Vol. 20, Iss. 7, pp. e3001709-e3001709
Open Access | Times Cited: 52
Interfering with Interferons: A Critical Mechanism for Critical COVID-19 Pneumonia
Helen C. Su, Huie Jing, Yu Zhang, et al.
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 561-585
Open Access | Times Cited: 34
Autoantibodies Neutralizing Type I IFNs in the Bronchoalveolar Lavage of at Least 10% of Patients During Life-Threatening COVID-19 Pneumonia
Quentin Philippot, Arnaud Fekkar, Adrian Gervais, et al.
Journal of Clinical Immunology (2023) Vol. 43, Iss. 6, pp. 1093-1103
Open Access | Times Cited: 25
Autoantibodies to Interferons in Infectious Diseases
Eugenia Quirós-Roldán, Alessandra Sottini, Simona Signorini, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1215-1215
Open Access | Times Cited: 15
Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases
Jérémie Rosain, Tom Le Voyer, Xian Liu, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 11
Open Access | Times Cited: 5
Auto-Abs neutralizing type I IFNs in patients with severe Powassan, Usutu, or Ross River virus disease
Adrian Gervais, Paul Bastard, Lucy Bizien, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 12
Open Access | Times Cited: 4
Human Genomics of COVID-19 Pneumonia: Contributions of Rare and Common Variants
Aurelié Cobat, Qian Zhang, Laurent Abel, et al.
Annual Review of Biomedical Data Science (2023) Vol. 6, Iss. 1, pp. 465-486
Open Access | Times Cited: 10
Anti-cytokine autoantibodies in human susceptibility to infectious diseases: insights from Inborn errors of immunity
Kosuke Noma, Takaki Asano, Maki Taniguchi, et al.
Immunological Medicine (2025), pp. 1-17
Open Access
Determination of the rate of autoantibody carrier state in patients with celiac disease by mono- and multiplex immunoassay
Nurana Nuralieva, M. Yu. Yukina, С В Быкова, et al.
Bulletin of Russian State Medical University (2025), Iss. 2025(2)
Open Access
Safety and efficacy of convalescent plasma for severe COVID-19: a randomized, single blinded, parallel, controlled clinical study
Manuel Rojas, Yhojan Rodríguez, Juan C. Hernández, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 15
Prevalence of Neutralizing Autoantibodies Against Type I Interferon in a Multicenter Cohort of Severe or Critical COVID-19 Cases in Shanghai
Dongling Shi, Jie Chen, Meng Zhao, et al.
Journal of Clinical Immunology (2024) Vol. 44, Iss. 3
Open Access | Times Cited: 3
Role of autoantibodies targeting interferon type 1 in COVID-19 severity: A systematic review and meta-analysis
Abolfazl Akbari, Alireza Hadizadeh, Mahdi Amiri, et al.
Journal of Translational Autoimmunity (2023) Vol. 7, pp. 100219-100219
Open Access | Times Cited: 8
In search of a function for human type III interferons: insights from inherited and acquired deficits
Qian Zhang, Kai Kisand, Yi Feng, et al.
Current Opinion in Immunology (2024) Vol. 87, pp. 102427-102427
Closed Access | Times Cited: 2
A sensitive assay for measuring whole-blood responses to type I IFNs
Adrian Gervais, Corentin Le Floc’h, Tom Le Voyer, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 40
Open Access | Times Cited: 2
Microarray Profiling of Vaccination-Induced Antibody Responses to SARS-CoV-2 Variants of Interest and Concern
Julia Svetlova, Dmitry Gustin, Valentin A. Manuvera, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13220-13220
Open Access | Times Cited: 8
Diagnostic Accuracy of Methods for Detection of Antibodies against Type I Interferons in Patients with Endocrine Disorders
Nurana Nuralieva, M. Yu. Yukina, Leila Sozaeva, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 12, pp. 1948-1948
Open Access | Times Cited: 5
Diagnostic Accuracy of Methods for Detection of Antibodies against Type I Interferons in Patients with Endocrine Disorders
Nurana Nuralieva, M. Yu. Yukina, Leila Sozaeva, et al.
(2022)
Open Access | Times Cited: 3
Impaired thymic AIRE expression underlies autoantibodies against type I IFNs in humans with inborn errors of the alternative NF-kB pathway
Tom Le Voyer, Adrian Gervais, Jérémie Rosain, et al.
Authorea (Authorea) (2023)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top